β2-microglobulin removal and plasma albumin levels with high cut-off hemodialysis

International Journal of Artificial Organs

Volumn 30, Issue 5, 2007, Pages 385-392

  Haase, Michael ^a,b   Bellomo, R ^a   Baldwin, I ^a   Haase Fielitz, A ^a,b   Fealy, N ^a   Morgera, S ^b   Goehl, H ^c   Storr, M ^c   Boyce, N ^a   Neumayer, H H ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Gambro Dialysatoren GmbH   (Germany)

Author keywords

Albumin; Clearance; Critical illness; Hemodialysis; High cut off membranes; 2 microglobulin

Indexed keywords

DISEASES; HEMODIALYZERS; NORMAL DISTRIBUTION; STATISTICAL METHODS;

ALBUMIN; CLEARANCE; CRITICAL ILLNESS; HAEMODIALYSIS; HIGH CUT-OFF MEMBRANE; HIGH FLUX; IN-VIVO; PLASMA ALBUMIN; PLASMA-Β; Β2-MICROGLOBULIN;

DIALYSIS;

ALBUMIN; BETA 2 MICROGLOBULIN; SERUM ALBUMIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIALYSATE LEVEL; DOUBLE BLIND PROCEDURE; FEMALE; HEMODIALYSIS; HUMAN; IN VIVO STUDY; INTERMETHOD COMPARISON; MALE; METHODOLOGY; OUTCOME ASSESSMENT; PLASMA CLEARANCE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; BLOOD; COMPARATIVE STUDY; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; AGED; BETA 2-MICROGLOBULIN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; RENAL DIALYSIS; SERUM ALBUMIN;

EID: 34447504974     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880703000505     Document Type: Article

References (20)

1. Vanholder R, Glorieux G, De Smet R, Lameire N. New insights in uremic toxins. Kidney Int 2003; 63 (suppl 84): S6-10.
2. Miyata T, Jadoul M, Kurokawa K, Van Ypersele de Strihou C. Beta-2 microglobulin in renal disease. J Am Soc Nephrol 1998; 9: 1723-35.
3. Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitomo T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T. A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. Biochem Biophys Res Commun 1985; 129: 701-6.
4. Canaud B, Morena M, Cristol JP, Krieter D. Beta2-microglobulin, a uremic toxin with a double meaning. Kidney Int 2006; 69: 1297-9.
5. Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T, et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 2006; 17: 546-55.
6. Gejyo F, Homma N, Hasegawa S, Arakawa M. A new therapeutic approach to dialysis amyloidosis: intensive removal of beta 2-microglobulin with adsorbent column. Int J Artif Organs 1993; 17: 240-3.
7. Canaud B, Assounga A, Kerr P, Aznar R, Mion C. Failure of a daily haemofiltration programme using a highly permeable membrane to return beta 2-microglobulin concentrations to normal in haemodialysis patients. Nephrol Dial Transplant 1992; 7: 924-30.
8. Krieter DH, Morgenroth A, Barasinski A, Lemke HD, Schuster O, von Harten B, Wanner C. Effects of a polyelectrolyte additive on the selective dialysis membrane permeability for low-molecular-weight proteins. Nephrol Dial Transplant 2007; 22: 491-9.
9. Abe T, Uchita K, Orita H, Kamimura M, Oda M, Hasegawa H, et al. Effect of beta(2)-microglobulin adsorption column on dialysis-related amyloidosis. Kidney Int 2003; 64: 1522-8.
10. Uchino S, Bellomo R, Goldsmith D, Davenport P, Cole L, Baldwin I, et al. Super high flux hemofiltration: a new technique for cytokine removal. Intensive Care Med 2002; 28: 651-5.
11. Lee WC, Uchino S, Fealy N, Baldwin I, Panagiotopoulos S, Goehi H, et al. Beta2-microglobulin clearance with super high flux hemodialysis: an ex vivo study. Int J Artif Organs 2003; 26: 723-7.
12. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-55.
13. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-12.
14. Nakazawa R, Azuma N, Suzuki M, Nakatani M, Nankou T, Furuyoshi S, et al. A new treatment for dialysis-related amyloidosis with beta 2-microglobulin adsorbent column. Int J Artif Organs 1993; 16: 823-9.
15. Pedrini LA, De Cristofaro V. On-line mixed hemodiafiltration with a feedback for ultrafiltration control: effect on middle-molecule removal. Kidney Int 2003; 64: 1505-13.
16. Lornoy W, Becaus I, Billiouw JM, Sierens L, Van Malderen P, D'Haenens P. On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations. Nephrol Dial Transplant 2000; 15 (suppl 1): S49-54.
17. Ward RA, Greene T, Hartmann B, Samtleben W. Resistance to intercompartmental mass transfer limits beta2-microglobulin removal by post-dilution hemodiafiltration. Kidney Int 2006; 69: 1431-7.
18. Odell RA, Slowiaczek P, Moran JE, Schindhelm K. Beta 2-microglobulin kinetics in end-stage renal failure. Kidney Int 1991; 39: 909-19.
19. Leypoldt JK, Cheung AK, Deeter RB. Single compartment models for evaluating beta 2-microglobulin clearance during hemodialysis. ASAIO J 1997; 43: 904-9.
20. Chanard J, Caudwell V, Valeire J, Vincent C, Randoux C, Wuillai A, Wynckel A. Kinetics of 131I-β2-microglobulin in hemodialysis patients: assessment using total body counting. Int J Artif Organs 1998; 22: 574-80.